Visceral Leishmaniasis co-existing with Multisystem Inflammatory Syndrome in a child

Elda Skenderi 1, *, Gjeorgjina Kuli-Lito ², Alberta Shkembi ³, Florinda Malaj 1, Anxhela Ruci 1, Besmira Bogdani 1 and Irisa Duka 1

¹ Pediatrician, General Pediatric Ward, University Hospital Center “Mother Tereza”, Tirana, Albania.
² Professor, Chef of Pediatric Infectious Disease Ward, University Hospital Center “Mother Tereza”, Tirana, Albania.
³ Psychologist, University Hospital Center “Mother Tereza”, Tirana, Albania.
 
Case Study
World Journal of Advanced Research and Reviews, 2023, 20(03), 1818–1823
Article DOI: 10.30574/wjarr.2023.20.3.2702
 
Publication history: 
Received on 21 November 2023; revised on 28 December 2023; accepted on 31 December 2023
 
Abstract: 
Leishmaniasis is a zoonotic disease caused by an intracellular protozoan parasite. The clinical spectrum of leishmaniasis ranges from a self-resolving cutaneous ulcer to Visceral leishmaniasis which is a serious, progressive, and potentially lethal systemic disease. “Multisystem Inflammatory Syndrome in Children” (MIS-C), which develops after the infection rather than during the acute stage of COVID-19 is a novel systemic syndrome that includes fever, elevated inflammatory parameters and organ dysfunction not attributed to other infectious causes. Here is presented a case the case of a 3-years old girl presented with persistent fever, and elevated inflammatory markers which was found to suffer simultaneously two severe conditions; Visceralis leishmaniasis and MIS-C. As these diseases have some similar clinical and laboratory features a high index of suspicion should be kept for both of them while valuating an ill child with fever and increased inflammatory markers.
 
Keywords: 
Visceralis leishmaniasis; MIS-C; Inflammation; Child; Diagnosis
 
Full text article in PDF: 
Share this